ACRP CP EXAM QUESTIONS AND
ANSWERS 100% PASS
1571 - ANS IND application; Permit to do research on humans for the first time; has
background info; and rationale; updated annually
1572 - ANS Investigator statement; commitment, done nationally and internationally by
sponsors intending to hava marketing aproval for IP
IB - ANS Clinical and non-clinical data on the investigational product that is relevant to the
study in human subjects; supplied prior to regulatory approval
Study type - Open Label - ANS everyone knows the treatment
Study type - Single blind - ANS one party knows Tx, usually the patient does not know but the
monitoring team does
Study type - Double Blind - ANS 2 or more people are blinded, usually the patient and
monitoring tram do not know which drug is given.
A 3rd party unblinded pharmacist is used and an unblinded CRA is needed
1 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
ANSWERS 100% PASS
1571 - ANS IND application; Permit to do research on humans for the first time; has
background info; and rationale; updated annually
1572 - ANS Investigator statement; commitment, done nationally and internationally by
sponsors intending to hava marketing aproval for IP
IB - ANS Clinical and non-clinical data on the investigational product that is relevant to the
study in human subjects; supplied prior to regulatory approval
Study type - Open Label - ANS everyone knows the treatment
Study type - Single blind - ANS one party knows Tx, usually the patient does not know but the
monitoring team does
Study type - Double Blind - ANS 2 or more people are blinded, usually the patient and
monitoring tram do not know which drug is given.
A 3rd party unblinded pharmacist is used and an unblinded CRA is needed
1 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
